TMCnet News

Research and Markets: 2013 Report on the International Aptamers Market Technology - Includes Forecasts to 2018
[December 17, 2013]

Research and Markets: 2013 Report on the International Aptamers Market Technology - Includes Forecasts to 2018


DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/7mw23f/aptamers_market) has announced the addition of the "2013 Report on the International Aptamers Market Technology - Includes Forecasts to 2018" report to their offering.

Aptamers is an emerging market sector, widely considered as a rival or substitute to antibodies in the scientific industry. It is poised to grow rapidly in various application areas, including therapeutics and diagnostics. The global aptamers market is valued at $287 million in 2013 and is expected to reach $2.1 billion by 2018. This research report categorizes the global aptamers market into geography, applications, and aptamer type. The applications market is further broken down by geography, with exhaustive revenue analysis for 2012 and 2013, as well as the forecast up to 2018.

In this report the aptamers market is analyzed both in terms of qualitative, i.e. technlogical and quantitative, i.e. revenue, perspectives. The technological analysis includes discussion on inherent characteristics and capabilities of aptamers over antibodies and the various applications where aptamers can find its place. The market revenue analysis includes market segmentation and the expected market position by 2018, with the projected growth rate.



The aptamers market is classified by geography, application segments and aptamer type. The application segments are further divided as therapeutics, diagnostics, biosensors, drug discovery, biomarker discovery, and research applications. The advantages of chemically modified aptamers and low production cost compared to antibodies aid the growth of the market.

Key Topics Covered:


1 Introduction

2 Executive Summary

3 Aptamers - Technology Landscape Analysis

4 Aptamers - Market Landscape Analysis

5 Technology Investment Potential

6 Aptamers - Technology Adoption And Development Potential

7 Aptamers Competitive Landscape

8 Intellectual Property And Research Strength Analysis

9 Analyst Insights And Recommendations

10 Company Profiles

Companies Mentioned:

  • AM Biotechnologies, Llc
  • Aptagen, LIC
  • Aptamatrix, Inc
  • Aptamer Sciences Inc
  • Aptamer Solutions Ltd
  • Aptares AG
  • Aptusbiotech
  • Base Pair Biotechnologies
  • Bioapter SL
  • Cd Genomics
  • Integrated Dna Technologies, Inc
  • Lucerna, Inc
  • NOXXON Pharma AG
  • Neoventures Biotechnology Inc
  • OTC Biotech
  • Ophthotech Corporation
  • Pfizer
  • Regado Biosciences, Inc
  • Somalogic, Inc
  • Trilink Biotechnologies, Inc
  • Vivonics

For more information visit http://www.researchandmarkets.com/research/7mw23f/aptamers_market


[ Back To TMCnet.com's Homepage ]